The circulating microRNome demonstrates distinct lymphocyte subset-dependent signatures

European Journal of Immunology

Volumn 46, Issue 3, 2016, Pages 725-731

  de Candia, Paola ^a   Torri, Anna ^a   Fedeli, Maya ^b   Viganò, Valentina ^b   Carpi, Donatella ^a   Gorletta, Tatiana ^a   Casorati, Giulia ^b   Pagani, Massimiliano ^a,c   Dellabona, Paolo ^b   Abrignani, Sergio ^a,c  

^a Istituto Nazionale di Genetica Molecolare   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Circulating microRNAs; Invariant natural killer T lymphocyteS; Lymphocyte subsets

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DICER; MICRORNA; MICRORNA 181B-5P; UNCLASSIFIED DRUG; CYTOKINE; DEAD BOX PROTEIN; DICER1 PROTEIN, MOUSE; RIBONUCLEASE III;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; WILD TYPE MOUSE; ANIMAL; BIOSYNTHESIS; BLOOD; CD8+ T LYMPHOCYTE; DEFICIENCY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DEAD-BOX RNA HELICASES; FLOW CYTOMETRY; MICE; MICRORNAS; NATURAL KILLER T-CELLS; RIBONUCLEASE III; T-LYMPHOCYTE SUBSETS;

EID: 84959340141     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545787     Document Type: Article

References (28)

1. Bartel, D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009. 136: 215-233.
2. Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., Calabro, E. et al., MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl. Acad. Sci. USA 2011. 108: 3713-3718.
3. Moussay, E., Wang, K., Cho, J. H., van Moer, K., Pierson, S., Paggetti, J., Nazarov, P. V. et al., MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 2011. 108: 6573-6578.
4. Taylor, D. D. and Gercel-Taylor, C., MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008. 110: 13-21.
5. D'Alessandra, Y., Devanna, P., Limana, F., Straino, S., Di Carlo, A., Brambilla, P. G., Rubino, M. et al., Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 2010. 31: 2765-2773.
6. Goretti, E., Vausort, M., Wagner, D. R. and Devaux, Y., Association between circulating microRNAs, cardiovascular risk factors and outcome in patients with acute myocardial infarction. Int. J. Cardiol. 2013. 168: 4548-4550.
7. Guay, C. and Regazzi, R., Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat. Rev. Endocrinol. 2013. 9: 513-521.
8. Starkey Lewis, P. J., Dear, J., Platt, V., Simpson, K. J., Craig, D. G., Antoine, D. J., French, N. S. et al., Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011. 54: 1767-1776.
9. Chen, Y. J., Zhu, J. M., Wu, H., Fan, J., Zhou, J., Hu, J., Yu, Q. et al., Circulating microRNAs as a fingerprint for liver cirrhosis. PLoS One 2013. 8: e66577.
10. Wang, J. F., Yu, M. L., Yu, G., Bian, J. J., Deng, X. M., Wan, X. J. and Zhu, K. M., Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Commun. 2010. 394: 184-188.
11. Roderburg, C., Luedde, M., Vargas Cardenas, D., Vucur, M., Scholten, D., Frey, N., Koch, A. et al., Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One 2013. 8: e54612.
12. Reid, G., Kirschner, M. B. and van Zandwijk, N., Circulating microRNAs: association with disease and potential use as biomarkers. Crit. Rev. Oncol. Hematol. 2011. 80: 193-208.
13. Trebicka, J., Anadol, E., Elfimova, N., Strack, I., Roggendorf, M., Viazov, S., Wedemeyer, I. et al., Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J. Hepatol. 2013. 58: 234-239.
14. de Candia, P., Torri, A., Gorletta, T., Fedeli, M., Bulgheroni, E., Cheroni, C., Marabita, F. et al., Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation. PLoS One 2013. 8: e75348.
15. Mittelbrunn, M., Gutierrez-Vazquez, C., Villarroya-Beltri, C., Gonzalez, S., Sanchez-Cabo, F., Gonzalez, M. A., Bernad, A. et al., Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2011. 2: 282.
16. Pagani, M., Rossetti, G., Panzeri, I., de Candia, P., Bonnal, R. J., Rossi, R. L., Geginat, J. et al., Role of microRNAs and long-non-coding RNAs in CD4(+) T-cell differentiation. Immunol. Rev. 2013. 253: 82-96.
17. Grusby, M. J., Johnson, R. S., Papaioannou, V. E. and Glimcher, L. H., Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 1991. 253: 1417-1420.
18. Van Kaer, L., Ashton-Rickardt, P. G., Ploegh, H. L. and Tonegawa, S., TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 1992. 71: 1205-1214.
19. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y. et al., Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.
20. Kitamura, D., Roes, J., Kuhn, R. and Rajewsky, K., A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991. 350: 423-426.
21. Cobb, B. S., Nesterova, T. B., Thompson, E., Hertweck, A., O'Connor, E., Godwin, J., Wilson, C. B. et al., T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 2005. 201: 1367-1373.
22. Guan, H., Fan, D., Mrelashvili, D., Hao, H., Singh, N. P., Singh, U. P., Nagarkatti, P. S. et al., MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2013. 43: 104-114.
23. Henao-Mejia, J., Williams, A., Goff, L. A., Staron, M., Licona-Limon, P., Kaech, S. M., Nakayama, M. et al., The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 2013. 38: 984-997.
24. Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S. and Van Kaer, L., CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997. 6: 469-477.
25. Kuchen, S., Resch, W., Yamane, A., Kuo, N., Li, Z., Chakraborty, T., Wei, L. et al., Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 2010. 32: 828-839.
26. Fedeli, M., Napolitano, A., Wong, M. P., Marcais, A., de Lalla, C., Colucci, F., Merkenschlager, M. et al., Dicer-dependent microRNA pathway controls invariant NKT cell development. J. Immunol. 2009. 183: 2506-2512.
27. Kirschner, M. B., Edelman, J. J., Kao, S. C., Vallely, M. P., van Zandwijk, N. and Reid, G., The impact of hemolysis on cell-free microRNA biomarkers. Front. Genet. 2013. 4: 94.
28. Blondal, T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang Teilum, M. and Dahlsveen, I. K., Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 2013. 59: S1-S6.